RegenXBio's market cap is currently $375.55M. The company's EPS TTM is $-5.034; its P/E ratio is ―; RegenXBio is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-1.14. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 90.24M	$ 112.72M	$ 470.35M	$ 154.57M	$ 35.23M
Gross Profit	$ 53.03M	$ 58.18M	$ 418.51M	$ 118.85M	$ 26.99M
Operating Income	$ -268.13M	$ -262.88M	$ 159.98M	$ -119.23M	$ -149.00M
EBITDA	$ -239.46M	$ -244.24M	$ 169.54M	$ -96.83M	$ -90.34M
Net Income	$ -263.49M	$ -280.32M	$ 127.84M	$ -111.25M	$ -94.73M
Balance Sheet
Cash & Short-Term Investments	$ 275.26M	$ 364.64M	$ 457.44M	$ 475.74M	$ 296.21M
Total Assets	$ 573.97M	$ 833.27M	$ 1.11B	$ 708.16M	$ 497.91M
Total Debt	$ 89.29M	$ 94.80M	$ 86.68M	$ 72.65M	$ 11.29M
Net Debt	$ 54.77M	$ -2.15M	$ -258.53M	$ -265.77M	$ -58.22M
Total Liabilities	$ 262.23M	$ 317.07M	$ 349.61M	$ 330.41M	$ 47.71M
Stockholders' Equity	$ 311.74M	$ 516.20M	$ 764.30M	$ 377.75M	$ 450.20M
Cash Flow
Free Cash Flow	$ -228.37M	$ -238.21M	$ 134.70M	$ -80.93M	$ -119.42M
Operating Cash Flow	$ -218.41M	$ -207.49M	$ 218.88M	$ -54.06M	$ -107.70M
Investing Cash Flow	$ 190.94M	$ -11.93M	$ -406.64M	$ 122.76M	$ 93.56M
Financing Cash Flow	$ -34.97M	$ -28.84M	$ 195.25M	$ 200.21M	$ 8.38M

Currency in USD

RegenXBio Earnings and Revenue History

Income Statement >

RegenXBio Debt to Assets

Balance Sheet >

RegenXBio Cash Flow

Cash Flow >

RegenXBio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing